A new Houston-developed AI model is being used in a clinical trial for the first time, and researchers are watching for more.

The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

The trial expansion was granted after RevBio demonstrated the safety of Tetranite in the first five treated patients.

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

NeuroSigma, Inc., a Los Angeles-based bioelectronics company, announced today that the Center for Evidence-Based Psychiatry ...